Download Citation
Article Source:
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma
Harrington BK,
Gardner HL,
Izumi R,
Hamdy A,
Rothbaum W,
et al.
(2016)
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
PLOS ONE 11(7): e0159607.
https://doi.org/10.1371/journal.pone.0159607